News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
416,190 Results
Type
Article (33402)
Company Profile (65)
Press Release (382714)
Multimedia
Podcasts (84)
Webinars (8)
Section
Business (113337)
Career Advice (1337)
Deals (24194)
Drug Delivery (116)
Drug Development (60095)
Employer Resources (105)
FDA (10297)
Job Trends (9143)
News (212939)
Policy (25773)
Tag
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (1863)
Accelerated approval (40)
Adcomms (27)
Allergies (125)
Alliances (42403)
ALS (131)
Alzheimer's disease (1395)
Antibody-drug conjugate (ADC) (287)
Approvals (10455)
Artificial intelligence (386)
Autoimmune disease (147)
Automation (28)
Bankruptcy (238)
Best Places to Work (7693)
BIOSECURE Act (16)
Biosimilars (162)
Biotechnology (44)
Bladder cancer (128)
Brain cancer (64)
Breast cancer (470)
Cancer (3884)
Cardiovascular disease (317)
Career advice (1147)
Career pathing (27)
CAR-T (202)
CDC (65)
Cell therapy (561)
Cervical cancer (29)
Clinical research (51345)
Collaboration (1559)
Company closure (4)
Compensation (1059)
Complete response letters (71)
COVID-19 (2610)
CRISPR (70)
C-suite (469)
Cystic fibrosis (89)
Data (4972)
Decentralized trials (2)
Denatured (13)
Depression (116)
Diabetes (420)
Diagnostics (3801)
Digital health (27)
Diversity (8)
Diversity, equity & inclusion (34)
Drug discovery (204)
Drug pricing (180)
Drug shortages (31)
Duchenne muscular dystrophy (227)
Earnings (43390)
Editorial (58)
Employer branding (13)
Employer resources (99)
Events (48868)
Executive appointments (466)
FDA (12742)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (12)
Frontotemporal dementia (21)
Funding (1022)
Gene editing (152)
Generative AI (39)
Gene therapy (520)
GLP-1 (988)
Government (4413)
Grass and pollen (6)
Guidances (309)
Healthcare (11455)
HIV (61)
Huntington's disease (44)
IgA nephropathy (69)
Immunology and inflammation (197)
Immuno-oncology (61)
Indications (109)
Infectious disease (2909)
Inflammatory bowel disease (127)
Inflation Reduction Act (11)
Influenza (124)
Intellectual property (172)
Interviews (233)
IPO (10550)
IRA (47)
Job creations (1757)
Job search strategy (962)
JPM (46)
Kidney cancer (12)
Labor market (55)
Layoffs (341)
Leadership (24)
Legal (7106)
Liver cancer (71)
Longevity (26)
Lung cancer (540)
Lymphoma (311)
Machine learning (35)
Management (33)
Manufacturing (637)
MASH (152)
Medical device (6098)
Medtech (6129)
Mergers & acquisitions (14558)
Metabolic disorders (1204)
mRNA (162)
Multiple sclerosis (122)
NASH (21)
Neurodegenerative disease (281)
Neuropsychiatric disorders (78)
Neuroscience (2405)
Neurotech (1)
NextGen: Class of 2026 (3667)
Non-profit (2803)
Now hiring (10)
Obesity (624)
Opinion (253)
Ovarian cancer (118)
Pain (131)
Pancreatic cancer (200)
Parkinson's disease (253)
Partnered (24)
Patents (347)
Patient recruitment (355)
Peanut (47)
People (25858)
Pharmaceutical (20)
Pharmacy benefit managers (20)
Phase 1 (15498)
Phase 2 (22309)
Phase 3 (18095)
Pipeline (5135)
Policy (296)
Postmarket research (1847)
Preclinical (6448)
Press Release (28)
Prostate cancer (200)
Psychedelics (45)
Radiopharmaceuticals (246)
Rare diseases (767)
Real estate (2615)
Recruiting (48)
Regulatory (18263)
Reports (25)
Research institute (1641)
Resumes & cover letters (198)
Rett syndrome (31)
RNA editing (9)
RSV (88)
Schizophrenia (130)
Series A (145)
Series B (109)
Service/supplier (3)
Sickle cell disease (66)
Special edition (13)
Spinal muscular atrophy (150)
Sponsored (31)
Startups (1919)
State (1)
Stomach cancer (14)
Supply chain (88)
Tariffs (71)
The Weekly (70)
Vaccines (1077)
Venture capital (68)
Weight loss (421)
Women's health (69)
Worklife (12)
Date
Today (51)
Last 7 days (410)
Last 30 days (1896)
Last 365 days (19730)
2026 (4711)
2025 (19914)
2024 (22357)
2023 (25262)
2022 (33389)
2021 (35898)
2020 (34080)
2019 (27913)
2018 (21234)
2017 (20195)
2016 (18699)
2015 (21502)
2014 (15952)
2013 (12883)
2012 (13630)
2011 (14404)
2010 (13082)
Location
Africa (583)
Alabama (54)
Alaska (3)
Arizona (128)
Arkansas (5)
Asia (27144)
Australia (4866)
California (7381)
Canada (2166)
China (870)
Colorado (294)
Connecticut (335)
Delaware (259)
Europe (65274)
Florida (1141)
Georgia (234)
Hawaii (4)
Idaho (30)
Illinois (542)
India (58)
Indiana (354)
Iowa (17)
Japan (385)
Kansas (79)
Kentucky (28)
Louisiana (20)
Maine (32)
Maryland (1042)
Massachusetts (5202)
Michigan (173)
Minnesota (269)
Mississippi (1)
Missouri (84)
Montana (21)
Nebraska (12)
Nevada (79)
New Hampshire (29)
New Jersey (2213)
New Mexico (15)
New York (2100)
North Carolina (870)
North Dakota (5)
Northern California (3733)
Ohio (205)
Oklahoma (10)
Oregon (14)
Pennsylvania (1491)
Puerto Rico (15)
Rhode Island (18)
South America (808)
South Carolina (37)
South Dakota (1)
Southern California (2876)
Tennessee (97)
Texas (957)
United States (26018)
Utah (167)
Vermont (1)
Virginia (191)
Washington D.C. (43)
Washington State (566)
West Virginia (2)
Wisconsin (68)
Wyoming (2)
416,190 Results for "eppendorf ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
GSK’s RSV Vaccine, AREXVY, Approved in US for Expanded Age Indication in Adults Aged 18–49 Years at Increased Risk
March 15, 2026
·
9 min read
Press Releases
Improving your biological age gap is associated with better brain health
March 5, 2026
·
4 min read
Press Releases
Allergan Aesthetics Ushers in a New Age of Hyaluronic Acid (HA) Injectables with JUVÉDERM® at AMWC Monaco
March 26, 2026
·
23 min read
Press Releases
Pharming Group announces approval of Joenja® (leniolisib) in Japan for the treatment of APDS in patients aged 4 years and older
March 24, 2026
·
8 min read
Press Releases
Bavarian Nordic Submits Data to EMA to Extend Mpox and Smallpox Vaccine Approval to Children Aged 2-11 Years
March 27, 2026
·
4 min read
Press Releases
Propanc Biopharma Executes Multi-Yr, Anti-Aging & Cancer Research Collaboration with the Universities of Jaén and Granada, Spain
March 24, 2026
·
4 min read
Press Releases
Allosteric Bioscience, Inc. Targets Optimizing Aging and Longevity: Quantum Computing, Advanced AI, Genomics
March 5, 2026
·
1 min read
Press Releases
Organic Longevity Biotechnology: A New Paradigm for Anti-Aging, Lifespan Extension, and Rejuvenation
February 20, 2026
·
1 min read
Press Releases
Memo Therapeutics AG’s Potravitug Granted Orphan Designation in the European Union
December 18, 2025
·
3 min read
Press Releases
Novartis Cosentyx® receives FDA approval for pediatric patients aged 12+ with moderate to severe hidradenitis suppurativa
March 15, 2026
·
11 min read
1 of 41,619
Next
